Austar Lifesciences Limited
AULSF
$0.07
$0.071,300.00%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.59% | -18.12% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.59% | -18.12% | |||
| Cost of Revenue | 0.59% | -19.68% | |||
| Gross Profit | 0.59% | -11.68% | |||
| SG&A Expenses | 0.59% | -13.05% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -0.58% | 43.10% | |||
| Total Operating Expenses | 0.59% | -19.16% | |||
| Operating Income | 0.59% | 36.46% | |||
| Income Before Tax | 0.59% | 150.04% | |||
| Income Tax Expenses | 0.59% | 154.17% | |||
| Earnings from Continuing Operations | 0.59% | 148.90% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.63% | 67.31% | |||
| Net Income | 0.59% | 142.35% | |||
| EBIT | 0.59% | 36.46% | |||
| EBITDA | 0.59% | 11.19% | |||
| EPS Basic | 0.00% | 142.86% | |||
| Normalized Basic EPS | 0.00% | 257.14% | |||
| EPS Diluted | 0.00% | 142.86% | |||
| Normalized Diluted EPS | 0.00% | 257.14% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||